UBS’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-2,600
Closed -$91K 10669
2014
Q2
$91K Sell
2,600
-50,400
-95% -$1.65M ﹤0.01% 6051
2014
Q1
$1.68M Sell
53,000
-14,200
-21% -$395K ﹤0.01% 2948
2013
Q4
$1.7M Buy
67,200
+47,400
+239% +$1.13M ﹤0.01% 2968
2013
Q3
$423K Buy
19,800
+7,900
+66% +$162K ﹤0.01% 4324
2013
Q2
$230K Buy
+11,900
New +$260K ﹤0.01% 4949

Other funds holding PTEN

UBS's PTEN Position: Q3 2014 in Review

UBS reduced its Patterson-UTI (PTEN) stake by 38% in Q3 2014, selling an estimated $5.98M and leaving 286,823 shares worth $9.33M. The position accounts for 0.01% of the portfolio, ranked #1508.

UBS first reported a position in PTEN in Q2 2013 and has held it in 6 quarters since. The position peaked at $16.2M in Q2 2014. 329 funds tracked by Wall St. Rank hold PTEN as of Q3 2014.

  • UBS held 286,823 shares of Patterson-UTI worth $9.33M as of Q3 2014.
  • UBS sold 176,039 Patterson-UTI shares in Q3 2014, an estimated $5.98M.
  • Patterson-UTI made up 0.01% of UBS's portfolio in Q3 2014, its #1508 holding.
  • UBS first reported a position in Patterson-UTI in Q2 2013 and has held it in 6 quarters since.
  • UBS's Patterson-UTI position peaked at $16.2M in Q2 2014.
  • 329 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.